Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

This article originally appeared here.
Share this content:
Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia
Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

THURSDAY, Sept. 10, 2015 (HealthDay News) -- For patients with relapsed or refractory hairy-cell leukemia, a short oral course of vemurafenib is highly effective, according to a study published online Sept. 9 in the New England Journal of Medicine.

Enrico Tiacci, M.D., from the Institute of Perugia in Italy, and colleagues conducted two phase 2, single-group, multicenter studies of oral vemurafenib in Italy (28 patients enrolled) and the United States (26 of 36 planned patients enrolled). Therapy was administered for a median of 16 and 18 weeks, respectively. The primary end points were the complete response rate and overall response rate, respectively.

The researchers found that after a median of eight weeks in the Italian study and 12 weeks in the U.S. study, the overall response rates were 96 and 100 percent, respectively. The rates of complete response in the two trials were 35 and 42 percent, respectively. The median relapse-free survival was 19 months among patients with a complete response and six months among those with a partial response in the Italian trial; median treatment-free survival was 25 and 18 months, respectively. At one year, the progression-free survival rate was 73 percent and overall survival was 91 percent in the U.S. trial.

"A short oral course of vemurafenib was highly effective in patients with relapsed or refractory hairy-cell leukemia," the authors write.

One author disclosed financial ties to Genentech, the manufacturer of vemurafenib.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »